Skip to main content
Picture of Shalise

Featured Patient Story

Shalise Gorrell

read more

Latest News Story Headlines

Alnylam Announces FDA Approval of AMVUTTRA® (vutrisiran), the First RNAi Therapeutic to Reduce Cardiovascular Death, Hospitalizations and Urgent Heart Failure Visits in Adults with ATTR Amyloidosis with Cardiomyopathy (ATTR-CM)

Mar 20, 2025

− Novel Mechanism of Action Delivers Rapid Knockdown of Transthyretin, Addressing the Disease at its Source –

read full article
Mystery Solved: New Research Reveals Why a Key Protein Turns Deadly in Aging Bodies
Mystery Solved: New Research Reveals Why a Key Protein Turns Deadly in Aging Bodies
 

By Scripps Research Institute

read full article
An Unexpected Benefit of Adding the Patient Voice to Medical Education—Train Providers to Be Better
An Unexpected Benefit of Adding the Patient Voice to Medical Education—Train Providers to Be Better

Mackenzie N.

read full article

Calendar & Upcoming Events

Webinar: Empowering Language: How Words Make a Difference

Webinar Session, Wednesday, March 26, 2025 at 6 PM (ET)  Zoom Meeting

view all event details

Heart Insights: A Conversation with an Amyloidosis-CM Cardiologist

Webinar Session: Wednesday, April 2nd, 2025 at 6 PM (ET)  Zoom Meeting

view all event details

Doable Nutrition Keys to Enhance Your Healing with Amyloidosis

view all event details

Amyloidosis Videos

Our Latest Webinar

Updates in AL amyloidosis: Fast Forward in 2024!

Heather Landau, MD - Memorial Sloan Kettering Cancer Center - New York, NY

Sign Up for the Latest Updates

Get news from Amyloidosis Foundation
in your inbox

By submitting this form, you are consenting to receive marketing emails from : Amyloidosis Foundation, 7151 N. Main St., Suite 2, Clarkston, MI, 48346, US, https://www.amyloidosis.org. You can revoke your consent to receive emails at any time by using SafeUnsubscribe© link, found at the bottom of every email. Emails are serviced by Constant Contract.